Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fuke Tengbai granules in chronic pelvic inflammatory disease
CTR20132442Phase 2Completed
- Sponsor
- Nanjing Shihao Pharmaceutical Technology
- Start
- Apr 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Fuke Tengbai Granules in Pelviabdominal infection, sponsored by Nanjing Shihao Pharmaceutical Technology. Started Apr 2014; status: completed.
02
Drugs
Fuke Tengbai Granules
03
Conditions
Pelviabdominal infection
Beyond the preview
Go deeper on CTR20132442.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20132442.